This is a Two-cohort, Exploratory Clinical Study Assessing the Activity of Benmelstobart Alone or Combined with Anlotinib Administered Prior to Surgery in Terms of Pathological Complete Response
Clinical trial NCT06851169 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06851169
- Sponsor
- Tang-Du Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-01
- Primary completion
- 2027-02-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.